Augmented mortality rate in breast cancer-afflicted patients with pre-existent metabolic disorders like obesity and diabetes, via impaired IGF-1 cues acting via S100A7/RAGE pathway, thereby promoting cancer-related angiogenesis in breast cancer micro-milieu, has been reported [78]. This evidence concerns the gene IGF1 and breast cancer.